• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telomir Pharmaceuticals, Inc. - Common Stock (NQ:TELO)

1.660 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telomir Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Today 7:30 EDT
Via ACCESS Newswire
Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer
October 14, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 09, 2025
 
Via Benzinga
Thursday's after hours session: top gainers and losers
October 09, 2025
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Why Telomir Pharmaceuticals Stock Is Rising 40% Premarket Today
October 09, 2025
Via Stocktwits
Telomir Pharmaceuticals Touts Promising Action From Its Lead Breast Cancer Drug
October 09, 2025
Telomir Pharmaceuticals' stock rises as Telomir-1 shows strong lab results against aggressive triple-negative breast cancer cells. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 09, 2025
 
Via Benzinga
Which stocks are moving before the opening bell on Thursday?
October 09, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 09, 2025
 
Via Benzinga
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
October 09, 2025
Via ACCESS Newswire
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
October 09, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 08, 2025
 
Via Benzinga
What's going on in today's after hours session
October 08, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
October 07, 2025
Via ACCESS Newswire
Stock Market Today: Dow Jones, Nasdaq Futures Slip Amid Delay In Trade Deficit Data During Shutdown—Trilogy Metals, AMD, Applovin In Focus
October 07, 2025
U.S. stock futures fell on Tuesday following Monday’s mixed moves. Futures of major benchmark indices were lower. 
Via Benzinga
Topics Stocks
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
October 07, 2025
 
Via Benzinga
McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday
October 07, 2025
U.S. stock futures mixed, key stocks to watch: MKC, SNWV, PENG, TELO, SAR. Check out premarket coverage. Cramer warns on chip stock. 
Via Benzinga
What's Behind The Sharp 39% After-Hours Rally In Telomir Pharmaceuticals?
October 06, 2025
Telomir's stock jumped nearly 39% in after-hours trading following news that its lead compound, Telomir-1, showed potential in reversing cancer-related DNA changes in aggressive prostate cancer... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 06, 2025
 
Via Benzinga
Wondering what's happening in today's after-hours session?
October 06, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Targets Additional Histone Demethylase Families, a Unique Profile in Cancer and Aging Not Seen in Other Therapies
September 18, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 09, 2025
 
Via Benzinga
Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
September 09, 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 29, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 28, 2025
 
Via Benzinga
Top movers in Thursday's after hours session
August 28, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
The market is filled with gapping stocks in Thursday's session.
August 28, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Wondering what's happening in today's pre-market session?
August 28, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 28, 2025
 
Via Benzinga
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
August 28, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap